Herbal Remedy for Diabetes: Two Case Reports

Abstract

We present case histories of two patients with type 2 diabetes who were taking herbal medicines that was claimed to be effective for the management of diabetes. Both patients had purchased their herbal medicines from India. On chemical analysis, these medicines were found to contain glibenclamide. Here we discuss the use of alternative medicines in the developed world and highlight the problem that adulteration of complimentary alternative medicines with modern medicines can cause in the management of diabetes.

diabetes mellitus - herbal remedy - adulteration - glibenclamide

References

• 1 Morrissey J, Shaikh S, Patel V. The Alphabet Strategy: A systematic approach to diabetes management.  Clinician in Management. 2005;  13 83-86
• 2 Jia W, Gao W, Tang L. Antidiabetic herbal drugs officially approved in China.  Phytother Res. 2003;  7 1127-1134
• 3 Ryan EA, Pick ME, Marceau C. Use of alternative medicines in diabetes mellitus.  Diabetic Med. 2001;  18 242-245
• 4 Ayurvedic Interventions for Diabetes Mellitus. . A Systematic Review.  , AHRQ Evidence Reports, 1–60→ 41, National Library of Medicine
• 5 Day C. Hypoglycaemic plant compounds.  Pract Diab Int. 1995;  12 269-271
• 6 Witters LA. The blooming of the French lilac.  J Clin Invest. 2001;  108 1105-1107
• 7 Wood MD, Athwal S, Panahloo A. Advantages and disadvantages of a ‘herbal’ medicine in a patient with diabetes: a case report.  Diabet Med. 2004;  21 625-627
• 8 Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan.  J Clin Pharmacol. 1997;  37 344-350
• 9 Roche A, Florkowski C, Walsmsley T. Lead poisoning due to ingestion of Indian herbal remedies.  N Z Med J. 2005;  29 ((118)) U1587
• 10 Lynch E, Braithwaite R. A review of the clinical and toxicological aspects of ‘traditional’ (herbal) remedies adulterated with heavy metals.  Expert Opin Drug Saf. 2005;  4 769-778
• 11 David ME, Ronald CK, Cindy F. et al . Unconventional medicine in the United States- Prevalence, costs, and patterns of use.  NEJM. 1993;  328 246-252

1 Competing interests: none to declare.

Correspondence